Effects of Depth of Needle Insertion
with Risperidone Long - Acting Injectable in Persons with Schizophrenia: A Randomized Double - Blind Study
Haloperidol was associated with higher risk of mortality (aHR 1.52; 95 % CI 1.14 — 2.02) and quetiapine with lower risk (aHR 0.84; 95 % CI 0.75 — 0.94) compared
with risperidone.
With the risperidone, the mice become obese and exhibit an alternative, less healthy shift in their microbiome,» Kirby says.
Not exact matches
For example, maladaptive aggression is common in ADHD, and clinical trial data suggest that at least one antipsychotic,
risperidone, when used
with stimulants, can help reduce aggression in ADHD.
Risperidone, the first drug approved for children
with autism and the most widely used, improves some behavior but can have severe side effects such as sleepiness and weight gain
Compared to the «basic group,» the «augmented group» who received the stimulant drug and parent training plus
risperidone showed significant improvement (on average
with moderately better behavior) on the Nisonger Child Behavior Rating Form (NCBRF) Disruptive - Total Scale, the NCBRF Social Competence subscale and the Reactive Aggression part of the Antisocial Behavior Scale.
Researchers found that the use of APMs in pregnancy does not meaningfully increase the risk of congenital malformations or cardiac malformations,
with the possible exception of
risperidone.
After controlling for other possible contributing mental and physical conditions and their associated behaviors, researchers found no significant increased risk for either congenital malformations or cardiac malformations among women who took either typical or atypical APMs in the first 90 days of pregnancy,
with the possible exception of
risperidone which continued to show a slightly increased risk.
For the «Treatment of Severe Childhood Aggression (TOSCA) Study,» 168 children (ages 6 - 12) who had been diagnosed
with ADHD and disruptive behavior disorder (DBD) and displayed severe physical aggression were randomly assigned to two groups: parent training plus stimulant plus placebo (Basic treatment) or parent training plus stimulant plus the antipsychotic drug
risperidone (Augmented treatment).
The generic
risperidone products will have the same safety warnings as Risperdal, including a boxed warning, cautioning that older patients
with dementia - related psychosis treated
with atypical anti-psychotic drugs are at increased risk of death, as compared
with those taking placebo.
The possible exception was
risperidone, which was associated
with a slightly increased risk.
After diagnosing her
with Asperger's syndrome and attention deficit hyperactivity disorder (ADHD), doctors placed her on
risperidone, an antipsychotic drug used to treat irritability and aggression in autistic children.
Her parents placed Katie — who has since been diagnosed
with a number of developmental, neurological, and emotional conditions — in a residential treatment facility, where she is now receiving care to be successfully removed from
risperidone.
[PMID 19996755] Serotonin transporter triallelic genotype and response to citalopram and
risperidone in dementia
with behavioral symptoms.
For example, antipsychotics such as
risperidone (Risperdal) and aripiprazole (Abilify) are prescribed to children to treat irritability associated
with autism.
A study published in the Journal of Clinical Psychopharmacology in 2006 reported that
risperidone, which is Risperdal's generic form, can strongly up the prolactin levels in adolescents,
with gynecomastia as a possible side effect.
The main purpose of this study was to improve mood and behavior disorders in RTT patients
with venlafaxine (SNRI), and compare the results
with citalopram (SSRIs) during 6 - 8 weeks, to determine which drug offered greater efficacy and fewer side effects, as well as to compare them to
risperidone, and to correlate cortisol levels in saliva
with stress and drug response.
Thirty six children aged 5 — 17 years
with an autism spectrum disorder (Autism Diagnostic Interview - Revised plus clinical judgement) enrolled in the open label phase, 24 children who responded to
risperidone were randomised.
Patients
with schizophrenia were being treated
with atypical antipsychotic medication (i.e., olanzapine,
risperidone, quetiapine, or aripiprazole).
Both stimulant - only and
risperidone treatment were associated
with clinical improvement.
Risperidone maintenance treatment increases time to symptom recurrence in young people
with disruptive behaviour disorders
An open - label trial using low doses (mean 1.2 ± 0.5 mg) of
risperidone in children and adolescents
with SMD showed significant reductions in irritability scores.17
Adding sarcosine, but not D - serine, to
risperidone improves symptoms in people
with acute phase schizophrenia
Our data support recent findings that higher doses of olanzapine (> 10 mg / d) are associated
with greater metabolic abnormalities.12 While data for
risperidone were inconclusive, 12 our data suggest a dose - response relationship at doses higher than 1.5 mg / d.
Review:
risperidone, olanzapine and haloperidol are the most effective drugs for acute mania in adults
with bipolar I disorder
It's especially common for teens
with autism to take one or two medicines,
risperidone or aripiprazole.
Two RCTs reported cannabis use outcomes following pharmacological interventions: one in people
with major depression, alcohol dependence and cannabis abuse diagnoses (n = 22; fluoxetine vs placebo) and one in people
with schizophrenia and cannabis and / or cocaine use disorders (n = 28; olanzapine vs
risperidone).
No medications are FDA - approved for the treatment of ODD in the U.S. Nonetheless, clinical experience has shown that the majority of children and adolescents
with ODD do show signs of improvement
with a low dose of atypical neuroleptics — arippirazole (Abilify) and
risperidone (Risperidal), for example.
Effects of
Risperidone and Parent Training on Adaptive Functioning in Children
With Pervasive Developmental Disorders and Serious Behavioral Problems Lawrence Scahill, M.S.N., Ph.D., Christopher J. McDougle, M.D., et.